ClinicalTrials.Veeva

Menu

Impact of the Diagnosis of Celiac Disease

T

Tampere University Hospital

Status

Completed

Conditions

Celiac Disease

Study type

Observational

Funder types

Other

Identifiers

NCT01145287
Burden-1

Details and patient eligibility

About

The main purpose of this study is to assess the impact of the diagnosis of celiac disease on general health, healthcare resource utilization, quality of life and lifestyle. We hypothesize that diagnosis and subsequent dietary treatment may have positive impact on these variables.

Full description

All new members with biopsy-proven celiac disease joining the Finnish Celiac Society will be categorized in three groups according to symptoms and signs leading to the diagnosis as classical symptoms, extraintestinal symptoms and screen-detected, the latest being further divided to those presenting with symptoms and those who are totally asymptomatic. Several parameters assessing general health and well-being, quality of life and healthcare resource utilization are evaluated at baseline and after one and five years on trial. Quality of life is compared to that of non-celiac controls.

Enrollment

760 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • diagnosis within one year
  • biopsy-proven diagnosis

Exclusion criteria

  • Celiac disease diagnosis previously than within one year
  • No biopsy-proven diagnosis

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems